Extramedullary myeloid cell tumours--the NIMS experience
T Roshni Paul1, C Sundaram, K Gayathri
1Department of Pathology, Nizam's Institute of Medical Sciences, Hyderabad.
Indian Journal of Pathology & Microbiology
|June 10, 2006
Summary
Extramedullary myeloid cell tumors (EMCTs) are rare and diagnostically challenging. This study reviewed 16 EMCT cases, detailing their varied locations and emphasizing the need for immunohistochemistry for accurate diagnosis and treatment.
Area of Science:
- Oncology
- Pathology
- Hematology
Background:
- Extramedullary myeloid cell tumors (EMCTs) are uncommon neoplasms.
- Their rarity often leads to diagnostic difficulties in clinical practice.
Purpose of the Study:
- To analyze the clinical and pathological features of EMCTs.
- To highlight diagnostic challenges and suggest immunohistochemical markers for accurate diagnosis and treatment.
Main Methods:
- Retrospective review of 16 EMCT cases over 14 years.
- Clinical data and follow-up information were collected.
- Morphological re-evaluation and immunohistochemistry (including LCA) were performed.
Main Results:
- EMCTs presented in diverse locations: skin, subcutaneous nodules, lymph nodes, extradural masses (causing cord compression), eyelid, orbit, and breast.
- Diagnostic challenges were identified in the reviewed cases.
Conclusions:
- Accurate diagnosis of EMCTs requires careful morphological assessment and specific immunohistochemical markers.
- Understanding the varied presentations is crucial for timely and appropriate patient management.
